SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charles Holewinski who wrote (939)11/25/1996 6:35:00 PM
From: John H. Farro   of 4342
 
Charles, I took your advice and I called Paracelsian this morning. The receptionist said that Babish and Koch were out of town. They'd probably be back by tomorrow. Since no one was there to answer my questions she gave me the name and number of someone I could talk to at their PR firm. I spoke to Andrew Keller of the P.L. Thomas Group. His phone number is (312) - 906-9080. He told me that Dr. Babish had intended to release the data from the Bastyr study at the conference when he was first invited in July. However, they had some trouble getting volunteers for the study right away. They ended up staggering when the volunteers started, so the study should be finished in December. He said they will probably issue a press release by the end of the year.

I asked him how many volunteers were in the study and could we infer that it was going well, based on the fact that they were planning on selling AndroVir in March. He said there were about 20 volunteers and that he couldn't give me an answer on how well the study was going because he didn't have the data, but that it was reasonable to assume that things were going ok based on the fact that they were planning on selling AndroVir so soon.

That's all the information I know. I feel a bit reassured.

Robin M.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext